Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Scientific Reports|March 12, 2017
Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis BEn-Qiang Chen, Shu Feng, Meng-Lan Wang, et al.Scientific Reports|March 31, 2017
Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver FailureEn-Qiang Chen, Meng-Lan Wang, Dong-Mei Zhang, et al.Medicine|October 30, 2020
Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination: Real-world experience of a retrospective studyJuan Li, Dong-Bo Wu, Wei Jiang, et al.Frontiers in Medicine|August 23, 2021
Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver FailureMeng-Lan Wang, Xiu-Jun Yin, Xue-Lian Li, et al.Annals of Hepatology|June 4, 2023
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavirFa- Da Wang, Jing Zhou, Lan-Qing Li, et al.Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|August 1, 2020
TRAIL inhibits HBV replication and expression by down-regulating liver-enriched transcription factorsJuan Li, Fan-Wei Liu, Dong-Bo Wu, et al.Clinics and Research in Hepatology and Gastroenterology|November 6, 2012
Expression of TRAIL in liver tissue from patients with different outcomes of HBV infectionFan-wei Liu, Dong-bo Wu, En-qiang Chen, et al.Virology Journal|January 20, 2012
Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infectionEn-Qiang Chen, Hui Sun, Ping Feng, et al.Frontiers in Medicine|September 16, 2021
Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and ConsensusJing Zhou, Fa-Da Wang, Meng-Lan Wang, et al.Stem Cell Reviews and Reports|November 22, 2023
Tracking of Stem Cells in Chronic Liver Diseases: Current Trends and DevelopmentsJin-Long He, Yi-Xian You, Xiong Pei, et al.Pageof 11